
A fast-rising strep bacterium has become increasingly notorious for causing serious infections in humans, including complications that can lead to muscle damage and patient death. New Houston Methodist research published in The American Journal of Pathology sheds light on how Streptococcus dysgalactiae subspecies equisimilis (SDSE) causes disease and may provide insights to aid vaccine development.
To better understand how SDSE causes disease compared with its better-known close relative, Strep A, Houston Methodist scientists, led by James Musser, MD, Ph.D., chair of the Department of Pathology and Genomic Medicine and director of the Center for Infectious Diseases at Houston Methodist, used a genomic screening method known as transposon-directed insertion-site sequencing (TraDIS) to test gene function in SDSE. The study examined two closely related SDSE strains, which helped detect subtle strain-specific differences that influence infection behavior.
“We identified several genes that were essential for bacterial survival in both laboratory and infection conditions,” Musser said. “The study also identified various genes in each strain that influenced the bacteria’s ability to grow and persist during muscle infection.”
Unexpectedly, several genes traditionally associated with Strep A infection were found to reduce survival and growth in SDSE when active, suggesting fundamental differences in how the two closely related bacteria cause disease.
“By defining which genes are truly required for growth and survival of the bacteria during infection, this work provides a foundation for understanding how SDSE causes severe disease and provides important information that may help in creating a SDSE vaccine,” Musser said.
The researchers said that as SDSE continues to be a threat, the findings provide a critical resource for future studies aimed at developing novel strategies to prevent and treat invasive SDSE infections.
Publication details
S.M. Nayeemul Bari et al, Gene Contribution of Streptococcus dysgalactiae Subspecies equisimilis, an Emerging Pathogen, to Experimental Primate Necrotizing Myositis, The American Journal of Pathology (2026). DOI: 10.1016/j.ajpath.2026.04.009
Journal information:
American Journal of Pathology
Clinical categories
The content is provided for information purposes only.
